Many of these men will have resistant disease, with little recourse. Current therapy works well, but we can do better!

A sarcoma is a rare kind of cancer. Although rare in adults, it only accounts for about 1% of all adult cancers, it represents approximately 15% of all childhood cancers. This #SarcomaAwarenessMonth, learn more from CancerDotNet: cprit.us/2KP86eL.

Congratulations, DrBagrodia!

Great work being done in the Kenneth S. Chen lab!

I'm grateful for the opportunity to share our work and get your valuable feedback! Next up for us: #SBUR19

#CPRIT funds critical cancer research. Renewing its funding ensures that this essential work can continue unabated! Well done Texas voters!

Check out our recent paper in European Urology! Serum miRNA outperform classical serum markers in predicting minimal residual disease in chemo-naive germ cell tumor patients. Advances in this area could improve treatment monitoring and prevent unnecessary surgeries!

As the year winds down, we’ll be celebrating the diversity of #devbio by tweeting some of our favourite papers of the year, showcasing different approaches, scales and species. It's the 12 days of #Devmas!

Hacking the 10x Genomics platform for 15x more cells & sample multiplexing. Combinatorial indexing + massively overloaded droplet-based scRNA-seq = scifi-RNA-seq. Preprint out now. biorxiv.org/content/10.110…

Are you going to a meeting? Check out our travel awards! Information for your application are in your email - inbox!

Join the PDA Career Development Committee for a seminar and case-study panel discussion led by @slschmid_lab on conflict management and collaboration on Monday February 24th!

In case you needed another reason to get your seasonal flu shot, here you go. TIL!

Cisplatin resistance is rare in TGCT, but it remains a major challenge. Nice work by Clare Turnbull- Prof/NHS Dr et al investigating genomic drivers of TGCT and mechanisms of cisplatin resistance!

Looking forward to hearing Genevieve Kendall, Ph.D.!

Proud of our multiD #testicularcancer team that provides expert, guideline-directed care regardless of ethnicity, insurance status at two hospitals with very different patient populations. -> = #tcsm Thx to UTSW Simmons Cancer Center and Parkland Health for the resources and support! @journalcancer

Hey @stranddw Gervaise H. Henry, I have a business proposition for you...

The hunt for a circulating marker for teratoma continues!

Congratulations Elena Vasileva and @amatrudalab! Great work!

Congrats, Rohit Badia! Happy to have had the chance to work together!

Completely agree! Great example of how revisiting data can provide additional insights.